Canaccord Genuity Maintains Hold on Amgen, Raises Price Target to $440

Benzinga · 2d ago
Canaccord Genuity analyst Gary Nachman maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $384 to $440.